Free Trial

MIRA Pharmaceuticals (MIRA) SEC Filings & 10K Form

MIRA Pharmaceuticals logo
$1.40 +0.03 (+1.82%)
As of 12:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent MIRA Pharmaceuticals SEC Filings

DateFilerForm TypeView
07/29/2025
4:26 PM
MIRA Pharmaceuticals (Filer)
Form PRER14A
07/28/2025
3:01 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2025
3:19 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2025
4:25 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2025
3:01 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2025
7:01 AM
MIRA Pharmaceuticals (Filer)
Form PREM14A
06/10/2025
6:12 AM
MIRA Pharmaceuticals (Issuer)
Weichselbaum Alan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/28/2025
7:00 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2025
4:25 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2025
4:28 PM
MIRA Pharmaceuticals (Filer)
Form 10-K/A
04/16/2025
4:17 PM
MIRA Pharmaceuticals (Filer)
Form 424B5
04/16/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2025
4:15 PM
MIRA Pharmaceuticals (Filer)
Form 10-K/A
04/11/2025
4:15 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2025
6:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
6:45 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
7:00 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
4:00 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
7:30 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
4:15 PM
Del Giudice Matthew Paul (Reporting)
MIRA Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:15 PM
MIRA Pharmaceuticals (Issuer)
Shekhat Denil Nanji (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:15 PM
Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:15 PM
MIRA Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:15 PM
MacPherson Edward Clouston (Reporting)
MIRA Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
4:15 PM
MIRA Pharmaceuticals (Issuer)
Whalen Matthew Pratt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
7:45 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
3:15 PM
Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
4:58 PM
Aminov Erez (Reporting)
MIRA Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
6:00 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
4:20 PM
MIRA Pharmaceuticals (Filer)
Form 424B5
09/27/2024
3:45 PM
MIRA Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/12/2024
3:30 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
3:01 PM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2024
3:38 PM
McNulty Brian Patrick (Reporting)
MIRA Pharmaceuticals (Subject)
Form 144/A
09/04/2024
7:20 PM
McNulty Brian Patrick (Reporting)
MIRA Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2024
11:15 PM
MIRA Pharmaceuticals (Filer)
Form EFFECT
Elon’s BIGGEST warning yet? (Ad)

Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.

Click here to see why Tesla's about to prove everyone wrong... again.
08/12/2024
7:37 AM
MIRA Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/08/2024
7:54 AM
MIRA Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MIRA) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners